Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 140,000 shares at $10.64 ($1.5M) on 2020-04-16, disclosed to the SEC on 2020-04-17.
Open-market purchase of $1.5M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.48 | 70,000 | $734K | 49.6% |
| 2 | $10.64 | 70,000 | $745K | 50.4% |
| Total | $10.56 avg | 140,000 | $1.5M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |